Heidelberg (pta037/13.07.2021/19:10) - 2invest AG (Frankfurt: 2INV; ISIN: DE000A3H3L44) has closed its first half of the financial year 2021 (01.01.2021 to 30.06.2021) with an expected net loss (financial statements according to HGB) of 192 TEUR and with freely available liquid funds (consisting of cash and bank balances plus liquid securities) of EUR 53.8 million as of 30 June 2021.
At the beginning of 2021, 2invest AG completed the transition from a functional and management holding company of a group of companies operating in the life sciences sector to an investment company. In this respect, the previous year's figures of the income statement for the period from 1 January 2020 to 30 June 2020 (1 HY 2020) of the company then operating under the name 4basebio AG, Heidelberg, are not comparable with the current 2invest AG. Therefore, no comparison with the previous year's figures for 1 HY 2020 is provided.
The preliminary result for the first half-year includes other operating income of 1,084 TEUR, consisting mainly of sales of marketable securities (980 TEUR) and personnel expenses of 101 TEUR, other operating expenses of 490 TEUR, depreciation of 14 TEUR and a financial result of EUR -670,000.
Other operating expenses mainly include legal and consulting costs (175 TEUR), capital market communication costs (80 TEUR), accounting and auditing costs (72 TEUR), costs due to the loss of input tax deductibility as a result of the change in the business model to an investment company (61 TEUR) and costs in connection with the KROMI takeover bid (31 TEUR).
The financial result of TEUR -670 is mainly composed of write-downs on marketable securities (TEUR 700), other interest and similar income (TEUR 70) and interest and similar expenses (TEUR 54).
The preliminary balance sheet as of 30 June 2021 in accordance with the German Commercial Code (HGB) shows equity of 84,309 TEUR (31 December 2020: 84,501 TEUR).
The aforementioned preliminary result is based on the preliminary assessment of the past first half of the 2021 financial year made by the Management Board on 13 July 2021. The figures stated in this announcement are subject to the final preparation of the half-year financial statements.
*** End of the ad hoc announcement***
For further information please contact:
Hansjörg Plaggemars, Board of Directors
Tel: +49 06221 649240
Ziegelhäuser Landstr. 3
|contact person:||Hansjörg Plaggemars|
|phone:||+49 6221 649 240|
|stock exchanges:||regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate|